Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Insulin Resistance 1Hyperandrogenism 1Glucose Intolerance 1Anovulation 1Adenomatous Polyposis Coli 1

Interventions

Metformin 12Clomiphene 6Inositol 3maltodextrin 2artenimol 2Thioctic Acid 2Tablets 2Sugars 2Spironolactone 2Pioglitazone 2Orlistat 2Contraceptives, Oral 2Cholecalciferol 2salicylsalicylic acid 1licogliflozin 1follitropin alfa 1elagolix 1Vitamin E 1Vitamin D 1Tooth Exfoliation 1Sodium Salicylate 1Root Planing 1Resveratrol 1Quercetin 1Pentoxifylline 1Ovulation Induction 1Linseed Oil 1Leuprolide 1Letrozole 1Inulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Polycystic Ovary Syndrome × Inulin × Clear all
NCT03864068 2026-01-07

INSUPP-PCOS

Milton S. Hershey Medical Center

Phase 2 Completed
154 enrolled

Anovulation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Glucose Intolerance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡